Pages that link to "Q68753926"
Jump to navigation
Jump to search
The following pages link to The effect of methotrexate on the bioavailability of oral 6-mercaptopurine (Q68753926):
Displaying 29 items.
- Mercaptopurine/Methotrexate maintenance therapy of childhood acute lymphoblastic leukemia: clinical facts and fiction (Q27023839) (← links)
- 6-Thioguanine in children with acute lymphoblastic leukaemia: influence of food on parent drug pharmacokinetics and 6-thioguanine nucleotide concentrations (Q28367546) (← links)
- 6-mercaptopurine dosage and pharmacokinetics influence the degree of bone marrow toxicity following high-dose methotrexate in children with acute lymphoblastic leukemia (Q32173689) (← links)
- Myelotoxicity after high-dose methotrexate in childhood acute leukemia is influenced by 6-mercaptopurine dosing but not by intermediate thiopurine methyltransferase activity (Q33418418) (← links)
- Therapeutic drug monitoring of antimetabolic cytotoxic drugs (Q33586713) (← links)
- The interaction of 6-mercaptopurine (6-MP) and methotrexate (MTX). (Q33752523) (← links)
- In vitro oxidative metabolism of 6-mercaptopurine in human liver: insights into the role of the molybdoflavoenzymes aldehyde oxidase, xanthine oxidase, and xanthine dehydrogenase (Q33942988) (← links)
- The clinical pharmacology of 6-mercaptopurine (Q34265967) (← links)
- Gene expression and thioguanine nucleotide disposition in acute lymphoblastic leukemia after in vivo mercaptopurine treatment (Q35848092) (← links)
- Prognostic significance of hepatotoxicity during maintenance chemotherapy for childhood acute lymphoblastic leukaemia (Q35982421) (← links)
- Redox control of leukemia: from molecular mechanisms to therapeutic opportunities (Q36646486) (← links)
- Drug interactions in childhood cancer (Q36898141) (← links)
- Reduced activities of cytochrome P450 1A2 and xanthine oxidase in children with growth hormone deficiency (Q37115549) (← links)
- Clinical pharmacology of cancer chemotherapy in children. (Q38700644) (← links)
- Pharmacologic considerations in the treatment of acute lymphoblastic leukemia (Q39522996) (← links)
- Antineoplastic agents. Drug interactions of clinical significance. (Q40449518) (← links)
- Pharmacokinetic drug interactions with anticancer drugs. (Q40694511) (← links)
- Schedule-dependent synergism and antagonism between methotrexate and 6-mercaptopurine in a human acute lymphoblastic cell line (Q41704620) (← links)
- Clinically relevant drug-drug interactions in oncology (Q42284655) (← links)
- Kinetics of 6-Thioxanthine Metabolism by Allelic Variants of Xanthine Oxidase (Q42918840) (← links)
- Intraindividual variation in 6-mercaptopurine pharmacokinetics during oral maintenance therapy of children with acute lymphoblastic leukaemia (Q43518396) (← links)
- Effect of methotrexate polyglutamates on thioguanine nucleotide concentrations during continuation therapy of acute lymphoblastic leukemia with mercaptopurine (Q43882750) (← links)
- Dose reduction of coadministered 6-mercaptopurine decreases myelotoxicity following high-dose methotrexate in childhood leukemia (Q44497845) (← links)
- Physiologically based pharmacokinetic modelling of methotrexate and 6-mercaptopurine in adults and children. Part 2: 6-mercaptopurine and its interaction with methotrexate (Q50476254) (← links)
- Variability of 6-mercaptopurine pharmacokinetics during oral maintenance therapy of children with acute leukemia (Q51623276) (← links)
- Clinical and experimental pharmacokinetic interaction between 6-mercaptopurine and methotrexate (Q70997284) (← links)
- Increased concentrations of methylated 6-mercaptopurine metabolites and 6-thioguanine nucleotides in human leukemic cells in vitro by methotrexate (Q74674407) (← links)
- Pharmacoepidemiological study of drug-drug interactions in onco-hematological pediatric patients (Q85280384) (← links)
- Prediction of leukocyte counts during paediatric acute lymphoblastic leukaemia maintenance therapy (Q91621147) (← links)